Maria Agallou
About
Maria Agallou is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Molecular Biology.
According to data from OpenAlex, Maria Agallou has authored 22 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 11 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Maria Agallou's work include Research on Leishmaniasis Studies (17 papers), vaccines and immunoinformatics approaches (6 papers) and Trypanosoma species research and implications (6 papers). Maria Agallou is often cited by papers focused on Research on Leishmaniasis Studies (17 papers), vaccines and immunoinformatics approaches (6 papers) and Trypanosoma species research and implications (6 papers). Maria Agallou collaborates with scholars based in Greece, France and Slovakia. Maria Agallou's co-authors include Evdokia Karagouni, Maritsa Margaroni, Evita Athanasiou, Olga Kammona, Costas Kiparissides, Eleni Dotsika, Olga S. Koutsoni, Despina Smirlis, Artemis G. Hatzigeorgiou and Catherine Gaitanaki and has published in prestigious journals such as PLoS ONE, Journal of Controlled Release and The Journal of Infectious Diseases.
In The Last Decade
Maria Agallou
22 papers receiving 481 citations
Peers
Maria Agallou
Fatemeh Torkashvand Iran
Evita Athanasiou Greece
Fernanda F. Ramos Brazil
Yevel Flores-García United States
Sarah E. Silk United Kingdom
Rajesh Ravindran India
Christian Muñoz Chile
Tapan Bhattacharyya United Kingdom
Iona J. Brian United Kingdom
Natasha Dubois Cauwelaert United States
Citations per year, relative to Maria Agallou Maria Agallou (= 1×)
peers
Fatemeh Torkashvand
Countries citing papers authored by Maria Agallou
Since
Specialization
Citations
This map shows the geographic impact of Maria Agallou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Agallou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Agallou more than expected).
Fields of papers citing papers by Maria Agallou
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Maria Agallou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Agallou. The network helps show where Maria Agallou may publish in the future.
Co-authorship network of co-authors of Maria Agallou
This figure shows the co-authorship network connecting the top 25 collaborators of Maria Agallou. A scholar is included among the top collaborators of Maria Agallou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Agallou. Maria Agallou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Backović, Marija, Maria Agallou, Marios Zouridakis, et al.. (2024). Novel Competitive ELISA Utilizing Trimeric Spike Protein of SARS-CoV-2, Could Identify More Than RBD-RBM Specific Neutralizing Antibodies in Hybrid Sera. Vaccines. 12(8). 914–914.
2.
Margaroni, Maritsa, et al.. (2023). Development of a novel squalene/α-tocopherol-based self-emulsified nanoemulsion incorporating Leishmania peptides for induction of antigen-specific immune responses. International Journal of Pharmaceutics. 649. 123621–123621.
3.
Agallou, Maria, Maritsa Margaroni, & Evdokia Karagouni. (2023). Intramuscular Immunization with a Liposomal Multi-Epitope Chimeric Protein Induces Strong Cellular Immune Responses against Visceral Leishmaniasis. Vaccines. 11(8). 1384–1384.
4.
Margaroni, Maritsa, et al.. (2023). Immunoinformatics Approach to Design a Multi-Epitope Nanovaccine against Leishmania Parasite: Elicitation of Cellular Immune Responses. Vaccines. 11(2). 304–304.
5.
Agallou, Maria, et al.. (2023). A liposomal vaccine promotes strong adaptive immune responses via dendritic cell activation in draining lymph nodes. Journal of Controlled Release. 356. 386–401.
6.
Agallou, Maria, et al.. (2022). Antibody and T-Cell Subsets Analysis Unveils an Immune Profile Heterogeneity Mediating Long-term Responses in Individuals Vaccinated Against SARS-CoV-2. The Journal of Infectious Diseases. 227(3). 353–363.
7.
Margaroni, Maritsa, Maria Agallou, Dimitra Karagkouni, et al.. (2022). Transcriptional Profiling of Leishmania infantum Infected Dendritic Cells: Insights into the Role of Immunometabolism in Host-Parasite Interaction. Microorganisms. 10(7). 1271–1271.
8.
Agallou, Maria, Maritsa Margaroni, Stathis D. Kotsakis, & Evdokia Karagouni. (2020). A Canine-Directed Chimeric Multi-Epitope Vaccine Induced Protective Immune Responses in BALB/c Mice Infected with Leishmania infantum. Vaccines. 8(3). 350–350.
9.
Agallou, Maria & Evdokia Karagouni. (2019). Detection of Antigen-specific T cells in Spleens of Vaccinated Mice Applying 3[H]-Thymidine Incorporation Assay and Luminex Multiple Cytokine Analysis Technology. BIO-PROTOCOL. 9(11). e3252–e3252.
10.
Agallou, Maria, Evita Athanasiou, Olga Kammona, et al.. (2019). Transcriptome Analysis Identifies Immune Markers Related to Visceral Leishmaniasis Establishment in the Experimental Model of BALB/c Mice. Frontiers in Immunology. 10. 2749–2749.
11.
Agallou, Maria, et al.. (2018). Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N-terminal domain of Leishmania infantum elongation factor-2 and CpG oligodeoxynucleotides. Molecular Immunology. 103. 7–20.
12.
Athanasiou, Evita, Maria Agallou, Spyros Tastsoglou, et al.. (2017). A Poly(Lactic-co-Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Leishmania infantum Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFNγ-Producing CD8+ T Cells Essential for the Protection against Experimental Visceral Leishmaniasis. Frontiers in Immunology. 8. 684–684.
13.
Margaroni, Maritsa, Maria Agallou, Evita Athanasiou, et al.. (2017). Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble <em>Leishmania</em> antigens and modified with a TNFα-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis. International Journal of Nanomedicine. Volume 12. 6169–6184.
14.
Margaroni, Maritsa, Maria Agallou, Konstantina Karidi, et al.. (2016). PLGA nanoparticles modified with a TNFα mimicking peptide, soluble Leishmania antigens and MPLA induce T cell priming in vitro via dendritic cell functional differentiation. European Journal of Pharmaceutics and Biopharmaceutics. 105. 18–31.
15.
Agallou, Maria, Evita Athanasiou, Martina Samiotaki, George Panayotou, & Evdokia Karagouni. (2016). Identification of Immunoreactive Leishmania infantum Protein Antigens to Asymptomatic Dog Sera through Combined Immunoproteomics and Bioinformatics Analysis. PLoS ONE. 11(2). e0149894–e0149894.
16.
Agallou, Maria, Evita Athanasiou, Olga S. Koutsoni, Eleni Dotsika, & Evdokia Karagouni. (2014). Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins. Frontiers in Immunology. 5. 268–268.
17.
Agallou, Maria, Eleni Dotsika, S. Frydas, & Evdokia Karagouni. (2014). Toll-like receptor 4 promotes control of Leishmania infantum infection through inducement of leishmanicidal activity in host macrophages: role of mitogen activated kinases.. PubMed. 28(1). 41–52.
18.
Agallou, Maria, et al.. (2013). In silico prediction of promiscuous Leishmania infantum KMP-11, H1, LeIF, CPA, CPB peptides and experimental validation of eliciting CD4+ and CD8+ T-cell specific responses. Frontiers in Immunology. 4.
19.
Agallou, Maria, Despina Smirlis, Ketty Soteriadou, & Evdokia Karagouni. (2012). Vaccination with Leishmania histone H1-pulsed dendritic cells confers protection in murine visceral leishmaniasis. Vaccine. 30(34). 5086–5093.
20.
Agallou, Maria, Maritsa Margaroni, & Evdokia Karagouni. (2011). Cellular vaccination with bone marrow-derived dendritic cells pulsed with a peptide of Leishmania infantum KMP-11 and CpG oligonucleotides induces protection in a murine model of visceral leishmaniasis. Vaccine. 29(31). 5053–5064.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Fatemeh Torkashvand Breakdown of academic impact, for papers by Evita Athanasiou Breakdown of academic impact, for papers by Fernanda F. Ramos Breakdown of academic impact, for papers by Yevel Flores-García Breakdown of academic impact, for papers by Sarah E. Silk Breakdown of academic impact, for papers by Rajesh Ravindran Breakdown of academic impact, for papers by Christian Muñoz Breakdown of academic impact, for papers by Tapan Bhattacharyya Breakdown of academic impact, for papers by Iona J. Brian Breakdown of academic impact, for papers by Natasha Dubois Cauwelaert